Company intelligence / Profile preview

MTS Medication Technologies

St. Petersburg, Florida, United States

Ownership: Private
Development stage: Other

Overview

MTS Medication Technologies was a leading provider of medication adherence packaging systems, developing automated packaging machinery and consumables for maximizing medication dispensing accuracy and safety in institutional and retail pharmacy settings. After its $156 million acquisition by Omnicell in 2012, its technology became part of Omnicell's broader pharmacy automation and medication management solutions portfolio.[1][2][4]

Industry: Therapeutic Medical Devices

Partnerships

Excellere Partners (previous investor, prior to Omnicell acquisition)Contec (manufacturing partner for MedLocker cabinet)[7]

Beyond the preview

Go deeper on MTS Medication Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTS Medication Technologies.

Explore the full profile